Security key
B5950S113
- Security type / class
- Equity / Ordinary Shares
- Total 13F shares
- 32,124
- Total 13F value
- $18,780
- Share change
- +32,000
- SEC-reported price per share
- $0.59
- Number of holders
- 3
- Value change
- +$18,707
- Number of buys
- 1
- Shares outstanding
- 95,174,297
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
3
Top holders
3
MDXH full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
MDxHealth SA SEC filings
MDxHealth SA company facts
Broader feeds
Reporting periods
Holder history for CUSIP B5950S113
Recent filing periods:
Ownership snapshot
Top reported holders of MDXH - MDxHealth SA - Ordinary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Laurence W. Lytton
Disclosed value leader
MVM Partners LLP
Comparable rows
2/15
Latest evidence
13 Aug 2026
13D/G
3/4/5
13F
Lead comparable stake: 20%
13 rows are not safely comparable across share classes.
13D/G row: Laurence W. Lytton
Showing 1-6 of 15 holder rows.
Quick read
Laurence W. Lytton leads the comparable SEC ownership view at 20%.
2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Laurence W. Lytton's linked filing trail.
Comparable ownership
Top 2
Laurence W. Lytton
20%
EXACT SCIENCES CORP
12%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Laurence W. Lytton |
13D/G
|
20%
Reported 13D/G
· 13 Aug 2026
|
$9,465,084
18,558,988 shares
|
+$6,943,917 | 13 Aug 2026 |
| EXACT SCIENCES CORP |
13D/G
Genomic Health, Inc.
|
12%
Reported 13D/G
· 09 Jan 2026
|
$22,608,510
6,441,171 shares
|
$0 | 09 Jan 2026 |
| MVM Partners LLP |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$105,351,696
26,337,924 shares
|
— | 04 Nov 2021 |
| Eric Bednarski |
3/4/5
Director
|
—
denominator unverified
|
$3,134,007
6,903,100 shares
|
+$1,000,000 | 13 Aug 2026 |
| MVM Partners, LLC |
3/4/5
13F
Director · Company
|
—
denominator unverified
|
$3,134,007
6,903,100 shares
|
+$1,000,000 | 13 Aug 2026 |
| Bleichroeder LP |
13F
Company
|
—
denominator unverified
|
$3,029,544
7,378,333 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
3
Shares
32,124
Rows available
3
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q4 2025 Across Filers
Q4 2025 holders
56
Q3 2026 holders
3
Holder diff
-53
| Investor | Q4 2025 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend